![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1662-6575|4|3|487-489
ISSN: 1662-6575
Source: Case Reports in Oncology, Vol.4, Iss.3, 2011-09, pp. : 487-489
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Future Role of Thalidomide in Multiple Myeloma
Acta Haematologica, Vol. 114, Iss. 1, 2005-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Maintenance Therapy for Multiple Myeloma with Particular Emphasis on Thalidomide
Oncology Research and Treatment, Vol. 29, Iss. 12, 2006-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Current Status of Thalidomide in the Management of Multiple Myeloma
Acta Haematologica, Vol. 114, Iss. 1, 2005-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Low-Dose Thalidomide for Multiple Myeloma: Interim Analysis of a Compassionate Use Program
Oncology Research and Treatment, Vol. 27, Iss. 2, 2004-05 ,pp. :